CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-15 | Subramanian Sanjay Chief Financial Officer | Option exercise | +7,990 | $2.19 | $17K | 53,581 |
| 2021-10-15 | Subramanian Sanjay Chief Financial Officer | Sale | −7,990 | $9.96 | $80K | 45,591 |
| 2021-10-15 | Subramanian Sanjay Chief Financial Officer | Option exercise · Option (Right to Buy) | −7,990 | 7,990 | ||
| 2021-09-15 | Musunuri Shankar Chief Executive Officer | Option exercise | +125,000 | $0.33 | $41K | 531,000 |
| 2021-09-15 | Musunuri Shankar Chief Executive Officer | Sale | −125,000 | $7.52 | $940K | 406,000 |
| 2021-09-15 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −125,000 | 1,201,587 | ||
| 2021-08-16 | Subramanian Sanjay Chief Financial Officer | Option exercise | +30,000 | $0.34 | $10K | 75,591 |
| 2021-08-16 | Subramanian Sanjay Chief Financial Officer | Sale | −30,000 | $7.22 | $217K | 45,591 |
| 2021-08-16 | Subramanian Sanjay Chief Financial Officer | Option exercise · Option (Right to Buy) | −30,000 | 246,170 | ||
| 2021-07-30 | Kompella Uday Director | Option exercise | +10,000 | $1.83 | $18K | 560,674 |
| 2021-07-30 | Kompella Uday Director | Sale | −10,000 | $6.81 | $68K | 550,674 |
| 2021-07-30 | Kompella Uday Director | Option exercise · Option (right to buy) | −10,000 | 106,000 | ||
| 2021-07-19 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2021-07-19 | Kumar Ramesh Director | Sale | −7,500 | $6.40 | $48K | 0 |
| 2021-07-19 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | −7,500 | 39,000 | ||
| 2021-07-15 | Subramanian Sanjay Chief Financial Officer | Option exercise | +31,086 | $0.34 | $11K | 76,677 |
| 2021-07-15 | Subramanian Sanjay Chief Financial Officer | Sale | −31,086 | $6.70 | $208K | 45,591 |
| 2021-07-15 | Subramanian Sanjay Chief Financial Officer | Option exercise · Options (Right to Buy) | −31,086 | 276,170 | ||
| 2021-06-25 | Kompella Uday Director | Option exercise | +10,000 | $1.83 | $18K | 560,674 |
| 2021-06-25 | Kompella Uday Director | Sale | −10,000 | $8.13 | $81K | 550,674 |
Page 9 of 27 · 525 trades